XML 35 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Benefit Plans (Tables)
6 Months Ended
Dec. 31, 2019
Benefit Plans  
Schedule of changes in the number of shares available for grant under equity incentive plans

    

Number of
Shares

 

Available for grant at July 1, 2019

9,759

RSUs granted

(638)

Shares withheld in settlement of taxes and/or exercise price

258

Forfeitures

80

Shares removed

(1)

Available for grant at December 31, 2019

9,458

Schedule of stock-based compensation expense related to stock options, restricted stock units and the Employee Stock Purchase Plan

Three Months Ended December 31, 

Six Months Ended December 31, 

    

2018

    

2019

    

2018

    

2019

 

Cost of revenues

$

1,304

$

1,446

$

2,542

$

2,695

Sales and marketing

 

2,000

 

3,379

 

3,697

 

7,347

Research and development

 

1,460

 

1,768

 

2,738

 

3,046

General and administrative

 

5,335

 

6,177

 

10,547

 

11,744

Total stock-based compensation expense

$

10,099

$

12,770

$

19,524

$

24,832

Schedule of stock option activity

Outstanding Options

 

    

    

    

Weighted

    

 

Weighted

average

 

average

remaining

Aggregate

 

Number of

exercise

contractual

intrinsic

 

shares

price

term (years)

value

 

Balance at July 1, 2019

 

1,525

$

12.24

 

3.95

$

124,373

Options exercised

(23)

$

17.35

Balance at December 31, 2019

 

1,502

$

12.17

3.43

$

163,219

Options vested and exercisable at December 31, 2019

 

1,502

$

12.17

3.43

$

163,219

Schedule of restricted stock unit activity

    

Units

    

Weighted
average
grant date
fair value

 

RSU balance at July 1, 2019

1,813

$

53.78

RSUs granted

638

$

99.48

RSUs vested

(688)

$

49.43

RSUs forfeited

(80)

$

57.65

RSU balance at December 31, 2019

1,683

$

73.21

RSUs expected to vest at December 31, 2019

1,553

$

72.66

Schedule of weighted average assumptions used for estimating grant date fair value of the ESPP

Six Months Ended

December 31, 

    

2018

2019

 

Valuation assumptions:

Expected dividend yield

0

%

0

%

Expected volatility

33.5 - 38.3

%

38.6 - 43.3

%

Expected term (years)

0.5

0.5

Risk‑free interest rate

2.10 - 2.48

%

1.58 - 2.44

%